Journal
CURRENT OPINION IN HIV AND AIDS
Volume 6, Issue 1, Pages 1-3Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/COH.0b013e328340ffa6
Keywords
antiretroviral therapy; HIV; HIV cure; latency; viral reservoirs
Categories
Funding
- Department of Veterans Affairs
- National Institutes of Health [AI69432, AI047745, AI080193]
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214, R01AI047745, P01AI080193] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Purpose of review Renewed interest has emerged to address the latent reservoir of HIV to achieve a cure. Recent findings The integrated proviral genome is a fundamental component of the retroviral replication cycle. The establishment of latently infected CD4(+) lymphocytes, and perhaps other as yet poorly characterized cells, represents a reservoir of HIV infection that is not appreciably affected by effective antiretroviral chemotherapy. Effective management of HIV infection, thus, will require lifelong treatment unless an approach to purging this reservoir is identified. Although substantial insights about the latent reservoir have been made, our understanding about the details of the reservoirs, the mechanisms of latency and potential targets to eliminate latently infected cells is too primitive to achieve a cure without a great deal of basic research to elucidate some of these areas. Summary A resurgence of interest in latent infection and its treatment promises progress in addressing the challenge of a cure, although, realistically, this will require a prolonged period of investigation in many areas.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available